Chai Discovery · Series A
Engineering better molecules using artificial intelligence for drug-like antibody design against challenging targets with atomic precision.
Amount
$70M
Round
Series A
Valuation
—
Announced
Aug 2025
Investors
Lead investor
Notes
Menlo Ventures led. AI drug discovery / molecular design.
Other Chai Discovery rounds
| Date | Round | Amount | |
|---|---|---|---|
| Dec 2025 | Series B | $130M | Details → |